Subtopic Deep Dive

Dry Powder Inhalers
Research Guide

What is Dry Powder Inhalers?

Dry powder inhalers (DPIs) are breath-actuated devices that deliver micronized powders directly to the lungs for pulmonary drug delivery without propellants.

DPIs rely on patient-generated airflow for powder deagglomeration and aerosolization. Key research focuses on particle engineering via spray drying and excipient selection for optimal flow and deposition (Vehring, 2007; Pilcer and Amighi, 2010). Over 1500 papers address DPI formulation and device design, with foundational works cited thousands of times.

15
Curated Papers
3
Key Challenges

Why It Matters

DPIs improve adherence for asthma and COPD patients by eliminating coordination issues of metered-dose inhalers (Bateman et al., 2007). Spray drying enables carrier-free formulations that enhance lung deposition efficacy (Vehring, 2007). Consensus guidelines highlight DPIs in new therapies for better airway targeting (Laube et al., 2011). Innovations reduce excipient needs, targeting chronic respiratory diseases with systemic delivery potential (Pilcer and Amighi, 2010).

Key Research Challenges

Powder Flow Variability

Powder cohesiveness causes inconsistent deagglomeration during inhalation. Patient airflow profiles vary, impacting aerosolization (Pilcer and Amighi, 2010). Spray drying controls morphology but struggles with hygroscopic drugs (Vehring, 2007).

Lung Deposition Optimization

Achieving deep lung delivery requires 1-5 μm particles amid anatomical barriers. Excipient ratios affect fine particle fraction but risk immunogenicity (Pilcer and Amighi, 2010). Device resistance influences velocity and deposition patterns (Laube et al., 2011).

Scalable Particle Engineering

Spray drying yields porous particles but faces yield losses at scale. Balancing density, size, and crystallinity remains difficult (Vehring, 2007). Microencapsulation adds stability but complicates aerosol performance (Laube et al., 2011).

Essential Papers

1.

Global strategy for asthma management and prevention: GINA executive summary

Eric D. Bateman, Suzanne S. Hurd, Peter J. Barnes et al. · 2007 · European Respiratory Journal · 3.2K citations

Asthma is a serious health problem throughout the world. During the past two decades, many scientific advances have improved our understanding of asthma and ability to manage and control it effecti...

2.

Pharmaceutical Particle Engineering via Spray Drying

Reinhard Vehring · 2007 · Pharmaceutical Research · 1.6K citations

3.

Violent expiratory events: on coughing and sneezing

Lydia Bourouiba, Eline Dehandschoewercker, John W. M. Bush · 2014 · Journal of Fluid Mechanics · 836 citations

Abstract Violent respiratory events such as coughs and sneezes play a key role in transferring respiratory diseases between infectious and susceptible individuals. We present the results of a combi...

4.

What the pulmonary specialist should know about the new inhalation therapies

Beth L. Laube, Hettie M. Janssens, Frans H. de Jongh et al. · 2011 · European Respiratory Journal · 782 citations

A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was facilitated by the European Respiratory Society (ERS) and the International Society for Aerosols in Medic...

5.

Formulation strategy and use of excipients in pulmonary drug delivery

Gabrielle Pilcer, Karim Amighi · 2010 · International Journal of Pharmaceutics · 753 citations

6.

Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery

Miléna Lengyel, Nikolett Kállai‐Szabó, Vince Antal et al. · 2019 · Scientia Pharmaceutica · 546 citations

Microparticles, microspheres, and microcapsules are widely used constituents of multiparticulate drug delivery systems, offering both therapeutic and technological advantages. Microparticles are ge...

7.

Nasal drug delivery devices: characteristics and performance in a clinical perspective—a review

Per G. Djupesland · 2012 · Drug Delivery and Translational Research · 513 citations

Nasal delivery is the logical choice for topical treatment of local diseases in the nose and paranasal sinuses such as allergic and non-allergic rhinitis and sinusitis. The nose is also considered ...

Reading Guide

Foundational Papers

Start with Vehring (2007) for spray drying basics, then Bateman et al. (2007) GINA for clinical context, and Pilcer and Amighi (2010) for excipient strategies—these cover core DPI engineering and applications with 5000+ combined citations.

Recent Advances

Laube et al. (2011) consensus on new therapies; Bourouiba et al. (2014) on expiratory flows affecting DPI performance.

Core Methods

Spray drying for porous particles (Vehring, 2007); carrier-based blending with lactose (Pilcer and Amighi, 2010); impinger testing for fine particle dose (Laube et al., 2011).

How PapersFlow Helps You Research Dry Powder Inhalers

Discover & Search

Research Agent uses searchPapers and citationGraph to map DPI literature from Vehring (2007, 1598 citations), revealing clusters around spray drying and excipients. exaSearch uncovers niche carrier-free formulations; findSimilarPapers extends to Pilcer and Amighi (2010).

Analyze & Verify

Analysis Agent applies readPaperContent to extract aerosolization data from Laube et al. (2011), then verifyResponse with CoVe checks deposition claims against GINA guidelines (Bateman et al., 2007). runPythonAnalysis simulates particle size distributions via NumPy; GRADE grades evidence on DPI efficacy.

Synthesize & Write

Synthesis Agent detects gaps in carrier-free DPI scalability post-Vehring (2007). Writing Agent uses latexEditText for formulation tables, latexSyncCitations for 10+ references, and latexCompile for manuscripts. exportMermaid visualizes aerosolization flowcharts.

Use Cases

"Analyze particle size distributions from DPI spray drying papers using Python."

Research Agent → searchPapers('spray drying DPI') → Analysis Agent → readPaperContent(Vehring 2007) → runPythonAnalysis(pandas plot of size histograms) → matplotlib graph of fine particle fraction.

"Draft a review section on DPI excipients with citations and table."

Research Agent → citationGraph(Pilcer 2010) → Synthesis Agent → gap detection → Writing Agent → latexEditText('excipient strategies') → latexSyncCitations → latexCompile → PDF with formatted table.

"Find code for simulating DPI airflow and deposition models."

Research Agent → paperExtractUrls('DPI computational fluid dynamics') → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for turbulence modeling output.

Automated Workflows

Deep Research workflow scans 50+ DPI papers via searchPapers, structures reports on formulation trends with GRADE scoring. DeepScan's 7-step chain verifies cough impacts on DPI efficacy (Bourouiba et al., 2014) using CoVe checkpoints. Theorizer generates hypotheses on excipient-free particles from Vehring and Pilcer citations.

Frequently Asked Questions

What defines dry powder inhalers?

DPIs are propellant-free devices using patient breath to aerosolize dry powders for lung delivery, optimized for 1-5 μm particles (Laube et al., 2011).

What are key methods in DPI research?

Spray drying engineers particle morphology for flowability (Vehring, 2007); excipients like lactose improve dispersion (Pilcer and Amighi, 2010).

What are foundational DPI papers?

Vehring (2007, 1598 citations) on spray drying; Bateman et al. (2007, 3203 citations) GINA guidelines; Pilcer and Amighi (2010, 753 citations) on excipients.

What are open problems in DPIs?

Scalable carrier-free powders, pediatric low-flow devices, and predicting in vivo deposition from in vitro data remain unsolved (Laube et al., 2011).

Research Inhalation and Respiratory Drug Delivery with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Dry Powder Inhalers with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers